SlideShare a Scribd company logo
Dr Santosh Kumar Bhaskar
Professor Anaesthesiology
Chirayu Medical College
Haemostatic Resuscitation
A 65-year-old male with a past history of ischaemic
heart disease is admitted to the ICU after a
motorcycle crash having sustained long bone
fractures of the lower limbs. He has no head, chest
or abdominal injuries.
Prior to surgery, his Glasgow Coma Scale (GCS) was
15 and Sp02 was 98% on 4 L/min oxygen via a
Hudson mask, and chest X-ray was normal. He
required prolonged operative fixation of his
fractures and that was complicated by significant
blood loss. Intra-operatively, he also developed an
increasing oxygen requirement.
On arrival in ICU, his most recent arterial blood gas,
taken on a Fi02 of 0.7 shows Pa02 of 55 mmHg (7.3
kPa).
Definition of hemostatic
resuscitation
 Rapid correction of haemostasis-
impairing factors, such as
hypothermia hypocalcemia and
acidosis
 Resuscitation with a balanced
combination of blood products,
which in combination resemble the
composition of whole blood, aiming
to avoid dilutional coagulopathy.
resuscitation:
 Reverse hypothermia
 Reverse acidosis
 Limit crystalloid load
 Use blood components in a proportion
which resembles whole blood
 Reverse fibrinolysis associated with
massive blood loss
 Achieve this whole-blood-like ratio within
the first 6 hours of resuscitation
Rationale for aggressive correction
of coagulopathy
 Exsanguination is a major cause of death
in trauma (40% of trauma-related death in
the first 24 hours is due to haemorrhage)
 Coagulopathy is common: 25% of severe
trauma patients are coagulopathic at
presentation
 According to retrospective cohort studies
(MacLeod et al, 2003) and the
coagulopathic patients have increased
mortality (46%) compared to non-
coagulopathic controls (11%).
Rationale for avoiding large
volumes of crystalloid
 Aggressive resuscitation with crystalloid leads to
haemodilution.
 Haemodilution decreases the concentration of clotting
factors and leads to coagulopathy.
 75% of the crystalloid volume load distributes into the
extravascular space; organ and tissue oedema
ensues, putting the patient at risk of pulmonary
oedema and abdominal compartment syndrome
(among other problems).
 Crystalloids do not contribute to the transport of
oxygen; by diluting the blood they actually decrease
its oxygen-carrying capacity.
 In the case of saline, crystalloid resuscitation may
exacerbate the acidosis.
Rationale for using a balanced
blood product ratio
 Transfusion of packed red cells does not restore
clotting factors.
 Coagulopathy will develop if packed red cells are the
sole resuscitation fluid.
 Transfused PRBCs suffer from storage lesions. Their
oxygen-carrying capacity isn't very good anyway.
 The citrate in the PRBCs tends to chelate the patient's
calcium; this can't be good for their clotting function.
 It stands to reason that whole blood is the best
resuscitation fluid to replace whole blood which is lost
by haemorrhage.
 A "balanced" ratio of blood products resembles whole
blood.
 The precise ratio of platelets plasma and PRBCs is
still being debated.
Rationale for correction of
acidosis
 Nonsurvivors of trauma are more likely to have
been acidotic than survivors
 Acidosis in trauma is largely the consequence of
raised lactate
 The lactate is generated not only by tissue
anaerobic metabolism, but also by the β-agonist
adrenergic effects of endogenous
catecholamines.
 The main problems with acidosis in trauma is its
influence on coagulopathy and haemodynamic
performance (Lier et al, 2008). In fact, acidosis
seems to be more important for coagulopathy
than the hypothermia (Hoffman et al, 2004)
Coagulopathy due to acidosis is the
result of multiple pathophysiological
processes
 The main problem is impaired thrombin generation.
The thrombin generation rate during the propagation
phase is impaired by 50% at a pH of 7.10.
 Platelet structure changes at a pH below 7.4: they
assume a spherical shape, and lose their
pseudopodia.
 Clotting factors function poorly -particularly Factors V,
VIIa and X- because the interaction between the
clotting factors and negatively charged phospholipids
is impaired at low pH (Hess et al, 2006).
 Decreased availability of ionised calcium (due to the
change in its protein binding dynamics)- therefore,
poor clotting function.
 Clotting factors which require iCa2+ have a decreased
affinity for it at a low pH.
 The haemodynamic effects of metabolic
acidosis are also counterproductive, particularly if
the pH is below 7.10:. Specific problems are
listed as follows.
Decreased cardiac output
Increased propensity to arrhythmias
Decreased systemic vascular tone
and arterial vasodilation
Decreased responsiveness to
catecholamines
Pulmonary vasoconstricition
Rationale for correcting
hypothermia
 Hypothermia seems to have a real impact on
trauma outcomes: in a retrospective analysis of
trauma patients (Jurkovich et al, 1987), the
temperature was associated with the following
mortality rates:
 Presenting temperature of over 34°C =
mortality of 7%;
 33-34°C = mortality of 40%;
 32-33°C = mortality of 67%,
 Under 32°C = mortality of 100%,
Effects
 In short, at 33°C the clotting activity is
suppressed to the point where it resembles a
50% reduction in clotting factor concentration
(even when the actual concentration is normal).
Interestingly, recombinant Factor VIIa
(Novoseven) still retains its activity at 34°C (+/-
2.5°C).
 Platelet activity is also impaired at low
temperature;Each 1°C decrease in temperature
results in a 15% decrease in the rate of
thromboxane B2 production (thus, platelet
Rationale for correction of
fibrinolysis with tranexamic acid
 One of the effects of trauma is to induce
a hyperfibrinolytic state
 The major source of this seem to be
increased serum levels of
thrombomodulin and tPA (Brohi et al,
2008)
 It would therefore make sense to give a
tPA inhibitor such as tranexamic acid or
eta-aminocaproic acid
Rationale for the use of
hypertonic saline
 After the resuscitation of trauma, massive tissue injury
and ischemia/reperfusion produces an exaggerated
systemic inflammatory response syndrome (SIRS) .
 Extravasation and sequestration of neutrophils into
vital organs is one of the main mechanisms of organ
damage in this context
 Hypertonic saline is said to have immunomodulatory
effects, specifically affecting neutrophil migration
(Angle et al, 2000) and decreasing the permeability of
the blood-brain barrier.
 As a hyperosmolar solution, it should theoretically
expand the volume of extracellular fluid by osmotically
"borrowing" water from the intracellular compartment-
Problems with haemostatic
resuscitation
 The ideal resuscitation fluid
would of course be whole blood.
Unfortunately, this is usually not
available. One may try to
recombine stored blood products
to achieve an end result which
resembles whole blood, but it is
never quite the same due to
lesions of processing and
storage.
 All blood products suffering storage
lesions are cold (contributing to
hypothermia) and acidic (because of
cellular metabolism in storage, as
well as due to citrate-based storage
media)
 The infusion of massive amounts of
blood products exposes the patient
to risks of massive transfusion which
are not trivial, and it is debatable
whether these risks outweigh the risks
of massive crystalloid load
 Tranexamic acid may have
prothrombotic effects which increase
the risk of DVT in already DVT-prone
trauma patients. Furthermore, the
methodology of the major trial in
support of its use makes it difficult to
generalise its finding to the ICU
setting
 Hypertonic saline can theoretically increase
the risk of bleeding by causing some sort of
platelet function impairment (fortunately
studies have demonstrated that one would
need to replace 10% of their blood volume
with hypertonic saline before one experiences
any of these effects).
Take home message
 Immediate resuscitation:
 Primary survey should include the
assessment of core temperature.
 Haemostasis by direct pressure wherever
this is possible
 ABG to determine the pH, lactate,
haemoglobin level and ionised calcium
 Activate the massive transfusion protocol in
liason with local blood bank and haematology
service
Take home message
 Organise transfusion: 1:1:1 FFP, platelets,
PRBCs.
 Haemoglobin level is not a valid transfusion
trigger, nor can transfusion wait for
haemoglobin levels to become available.
 Any transfused blood products should be
warmed with a heater. Six units of RBCs at
4ºC will reduce the body temperature of an
average 70 kg adult by 1ºC.
 Crystalloid is to be avoided unless there is
no other option and haemodynamic
performance if life-threateningly poor
Take home message
 Tranexamic acid 1g over 10
minutes
 Correct ionised calcium
 Commence warming the patient
externally
 Practice permissive hypotension is
permitted by the absence of
neurotrauma
 Within the first 6 hours:
Take home message
 Coags data, plus/minus TEG or ROTEM (its
utility and cost effectiveness over traditional
coags is still being questioned) will guide the
ongoing use of blood products.
 Tranexamic acid 1g over 8 hours to chase the
first dose (as per CRASH-2 protocol)
 Cryoprecipitate 3-4g should be given if the
fibrinogen level is below 1.0
 Recombinant Factor VIIa (Novoseven) should
be thought about if the coags are trending
towards normal, and the patient is still
exsanguinating (the dose should be 90 μg/kg)
Thanks for
patients
hearing

More Related Content

What's hot

SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)
SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)
SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)
د. أنور الموسوي
 
Hemodialysis in children
Hemodialysis in childrenHemodialysis in children
Hemodialysis in children
FarragBahbah
 
Blood component therapy
Blood component therapyBlood component therapy
Blood component therapy
anaesthesiology-mgmcri
 
INTRA VENOUS FLUID THERAPY
INTRA VENOUS FLUID THERAPYINTRA VENOUS FLUID THERAPY
INTRA VENOUS FLUID THERAPY
Agrawal N.K
 
Red cell transfusions in the critically ill compatible
Red cell transfusions in the critically ill compatibleRed cell transfusions in the critically ill compatible
Red cell transfusions in the critically ill compatibleBharath T
 
Massive transfusion
Massive transfusionMassive transfusion
Massive transfusionRafiq Ahmad
 
General Surgery ~~ Fluid management in Adults
General Surgery ~~ Fluid management in AdultsGeneral Surgery ~~ Fluid management in Adults
General Surgery ~~ Fluid management in Adults
Yu-Hao Huang
 
Trauma resuscitation
Trauma resuscitationTrauma resuscitation
Trauma resuscitation
SCGH ED CME
 
Renal replacement in children
Renal replacement in childrenRenal replacement in children
Renal replacement in children
Lokeshnrgowda Lokesh
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
Magdy Shafik M. Ramadan
 
Anticoagulation in hemodialysis
Anticoagulation in hemodialysisAnticoagulation in hemodialysis
Anticoagulation in hemodialysisVishal Ramteke
 
Massive transfusion
Massive transfusionMassive transfusion
Massive transfusion
Arthi Rajasankar
 
Shock & Haemorrhage, Blood Transfusion, Blood Products
Shock & Haemorrhage, Blood Transfusion, Blood ProductsShock & Haemorrhage, Blood Transfusion, Blood Products
Shock & Haemorrhage, Blood Transfusion, Blood Products
Dr. Anick Saha Shuvo
 
Fluid management in icu dr vijay
Fluid management in icu dr vijayFluid management in icu dr vijay
Fluid management in icu dr vijay
Vijay Kumar
 
Peritoneal dialysis in children
Peritoneal dialysis in childrenPeritoneal dialysis in children
Peritoneal dialysis in children
Nakisa Hooman
 
Blood and blood transfusion
Blood and blood transfusionBlood and blood transfusion
Blood and blood transfusion
Bashir BnYunus
 
Massive transfusion
Massive transfusionMassive transfusion
Massive transfusion
KIMS
 
Fluid therapy in children
Fluid therapy in childrenFluid therapy in children
Fluid therapy in children
Ali S. Mayali
 
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysis
أحمد عبد الوهاب الجندي
 

What's hot (20)

SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)
SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)
SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)
 
Hemodialysis in children
Hemodialysis in childrenHemodialysis in children
Hemodialysis in children
 
Blood component therapy
Blood component therapyBlood component therapy
Blood component therapy
 
INTRA VENOUS FLUID THERAPY
INTRA VENOUS FLUID THERAPYINTRA VENOUS FLUID THERAPY
INTRA VENOUS FLUID THERAPY
 
Red cell transfusions in the critically ill compatible
Red cell transfusions in the critically ill compatibleRed cell transfusions in the critically ill compatible
Red cell transfusions in the critically ill compatible
 
Massive transfusion
Massive transfusionMassive transfusion
Massive transfusion
 
General Surgery ~~ Fluid management in Adults
General Surgery ~~ Fluid management in AdultsGeneral Surgery ~~ Fluid management in Adults
General Surgery ~~ Fluid management in Adults
 
Trauma resuscitation
Trauma resuscitationTrauma resuscitation
Trauma resuscitation
 
Renal replacement in children
Renal replacement in childrenRenal replacement in children
Renal replacement in children
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 
Anticoagulation in hemodialysis
Anticoagulation in hemodialysisAnticoagulation in hemodialysis
Anticoagulation in hemodialysis
 
Massive transfusion
Massive transfusionMassive transfusion
Massive transfusion
 
dvt prophylaxis
dvt prophylaxisdvt prophylaxis
dvt prophylaxis
 
Shock & Haemorrhage, Blood Transfusion, Blood Products
Shock & Haemorrhage, Blood Transfusion, Blood ProductsShock & Haemorrhage, Blood Transfusion, Blood Products
Shock & Haemorrhage, Blood Transfusion, Blood Products
 
Fluid management in icu dr vijay
Fluid management in icu dr vijayFluid management in icu dr vijay
Fluid management in icu dr vijay
 
Peritoneal dialysis in children
Peritoneal dialysis in childrenPeritoneal dialysis in children
Peritoneal dialysis in children
 
Blood and blood transfusion
Blood and blood transfusionBlood and blood transfusion
Blood and blood transfusion
 
Massive transfusion
Massive transfusionMassive transfusion
Massive transfusion
 
Fluid therapy in children
Fluid therapy in childrenFluid therapy in children
Fluid therapy in children
 
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysis
 

Similar to Haemostatic resuscitation

Emergency Fluid Therapy
Emergency Fluid TherapyEmergency Fluid Therapy
Emergency Fluid TherapyRashidi Ahmad
 
Biochemical changes in stored blood
Biochemical changes in stored bloodBiochemical changes in stored blood
Biochemical changes in stored blood
Moustafa Rezk
 
Fluids in Intensive Care
Fluids in Intensive Care Fluids in Intensive Care
Fluids in Intensive Care
Vineel Bezawada
 
Fluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive TransfusionFluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive TransfusionAndrew Ferguson
 
Tom woodcock - steady state starling principle - IFAD2017
Tom woodcock - steady state starling principle - IFAD2017Tom woodcock - steady state starling principle - IFAD2017
Tom woodcock - steady state starling principle - IFAD2017
International Fluid Academy
 
Perioperative fluid therapy
Perioperative fluid therapyPerioperative fluid therapy
Perioperative fluid therapy
anaesthesiology-mgmcri
 
Fluid management in ICU
Fluid management in ICUFluid management in ICU
Fluid management in ICU
Ahmed Elsaid
 
Hypothermia and dhca
Hypothermia and dhcaHypothermia and dhca
Hypothermia and dhca
drabhimishra83
 
Partial Exchange Transfussion In Polycythemia Secondary To Complex Cyanotic H...
Partial Exchange Transfussion In Polycythemia Secondary To Complex Cyanotic H...Partial Exchange Transfussion In Polycythemia Secondary To Complex Cyanotic H...
Partial Exchange Transfussion In Polycythemia Secondary To Complex Cyanotic H...AR Muhamad Na'im
 
2.colloids
2.colloids2.colloids
2.colloids
Richie Sanam
 
Priming and Hemodilution
Priming and HemodilutionPriming and Hemodilution
Priming and Hemodilution
Muhammad Badrushshalih
 
shock marker
shock markershock marker
shock markerEM OMSB
 
Massive Transfusion: Where are We Now?
Massive Transfusion: Where are We Now?Massive Transfusion: Where are We Now?
Massive Transfusion: Where are We Now?
Apollo Hospitals
 
Pharmacotherapy of shock ppt
Pharmacotherapy of shock pptPharmacotherapy of shock ppt
Pharmacotherapy of shock ppt
Rashmin Kulabkar
 
Shock and blood transfusion
Shock and blood transfusionShock and blood transfusion
Shock and blood transfusion
CHANDRAKANT SABALE
 
Hypovolemic shock
Hypovolemic shockHypovolemic shock
Hypovolemic shock
Shaurya Pratap Singh
 
lacticacidosis-150216102857-conversion-gate02.pdf
lacticacidosis-150216102857-conversion-gate02.pdflacticacidosis-150216102857-conversion-gate02.pdf
lacticacidosis-150216102857-conversion-gate02.pdf
ElhamAlwagaa
 
Lactic Acidosis-An update
Lactic Acidosis-An updateLactic Acidosis-An update
Lactic Acidosis-An update
Suneth Weerarathna
 
APPROACH TO TRAUMATIC SHOCK
APPROACH TO TRAUMATIC SHOCKAPPROACH TO TRAUMATIC SHOCK
APPROACH TO TRAUMATIC SHOCK
ASHMAL
 
balanced salt.pptx
balanced salt.pptxbalanced salt.pptx
balanced salt.pptx
aceforum
 

Similar to Haemostatic resuscitation (20)

Emergency Fluid Therapy
Emergency Fluid TherapyEmergency Fluid Therapy
Emergency Fluid Therapy
 
Biochemical changes in stored blood
Biochemical changes in stored bloodBiochemical changes in stored blood
Biochemical changes in stored blood
 
Fluids in Intensive Care
Fluids in Intensive Care Fluids in Intensive Care
Fluids in Intensive Care
 
Fluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive TransfusionFluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive Transfusion
 
Tom woodcock - steady state starling principle - IFAD2017
Tom woodcock - steady state starling principle - IFAD2017Tom woodcock - steady state starling principle - IFAD2017
Tom woodcock - steady state starling principle - IFAD2017
 
Perioperative fluid therapy
Perioperative fluid therapyPerioperative fluid therapy
Perioperative fluid therapy
 
Fluid management in ICU
Fluid management in ICUFluid management in ICU
Fluid management in ICU
 
Hypothermia and dhca
Hypothermia and dhcaHypothermia and dhca
Hypothermia and dhca
 
Partial Exchange Transfussion In Polycythemia Secondary To Complex Cyanotic H...
Partial Exchange Transfussion In Polycythemia Secondary To Complex Cyanotic H...Partial Exchange Transfussion In Polycythemia Secondary To Complex Cyanotic H...
Partial Exchange Transfussion In Polycythemia Secondary To Complex Cyanotic H...
 
2.colloids
2.colloids2.colloids
2.colloids
 
Priming and Hemodilution
Priming and HemodilutionPriming and Hemodilution
Priming and Hemodilution
 
shock marker
shock markershock marker
shock marker
 
Massive Transfusion: Where are We Now?
Massive Transfusion: Where are We Now?Massive Transfusion: Where are We Now?
Massive Transfusion: Where are We Now?
 
Pharmacotherapy of shock ppt
Pharmacotherapy of shock pptPharmacotherapy of shock ppt
Pharmacotherapy of shock ppt
 
Shock and blood transfusion
Shock and blood transfusionShock and blood transfusion
Shock and blood transfusion
 
Hypovolemic shock
Hypovolemic shockHypovolemic shock
Hypovolemic shock
 
lacticacidosis-150216102857-conversion-gate02.pdf
lacticacidosis-150216102857-conversion-gate02.pdflacticacidosis-150216102857-conversion-gate02.pdf
lacticacidosis-150216102857-conversion-gate02.pdf
 
Lactic Acidosis-An update
Lactic Acidosis-An updateLactic Acidosis-An update
Lactic Acidosis-An update
 
APPROACH TO TRAUMATIC SHOCK
APPROACH TO TRAUMATIC SHOCKAPPROACH TO TRAUMATIC SHOCK
APPROACH TO TRAUMATIC SHOCK
 
balanced salt.pptx
balanced salt.pptxbalanced salt.pptx
balanced salt.pptx
 

More from santoshbhskr

Ats guidelines for cap 2019
Ats guidelines for cap 2019Ats guidelines for cap 2019
Ats guidelines for cap 2019
santoshbhskr
 
Fluid Therapy in critically ill
Fluid Therapy  in critically illFluid Therapy  in critically ill
Fluid Therapy in critically ill
santoshbhskr
 
Perioperative optimisation for surgery
Perioperative optimisation for surgeryPerioperative optimisation for surgery
Perioperative optimisation for surgery
santoshbhskr
 
Kill chararteristic of antibiotics
Kill chararteristic of antibioticsKill chararteristic of antibiotics
Kill chararteristic of antibiotics
santoshbhskr
 
Complicated intra abdominal infection
Complicated intra abdominal infectionComplicated intra abdominal infection
Complicated intra abdominal infection
santoshbhskr
 
Hyperglycemia in critically ill patients
Hyperglycemia in critically ill patientsHyperglycemia in critically ill patients
Hyperglycemia in critically ill patients
santoshbhskr
 
Acute Kidney injury in icu
Acute Kidney injury in icuAcute Kidney injury in icu
Acute Kidney injury in icu
santoshbhskr
 
Prevention of adverse drug events in hospital
Prevention of adverse drug events  in hospitalPrevention of adverse drug events  in hospital
Prevention of adverse drug events in hospital
santoshbhskr
 
Thromboprophylaxis in icu
Thromboprophylaxis in icuThromboprophylaxis in icu
Thromboprophylaxis in icu
santoshbhskr
 
Nutritional requirement in critically ill
Nutritional requirement in  critically illNutritional requirement in  critically ill
Nutritional requirement in critically ill
santoshbhskr
 
Anticoagulation guidelines recent update 2016
Anticoagulation guidelines recent update 2016Anticoagulation guidelines recent update 2016
Anticoagulation guidelines recent update 2016
santoshbhskr
 
Ventilation quiz question
Ventilation  quiz questionVentilation  quiz question
Ventilation quiz question
santoshbhskr
 
Case study myasthenia gravis
Case study myasthenia gravisCase study myasthenia gravis
Case study myasthenia gravis
santoshbhskr
 
Crystalloid fluid therapy
Crystalloid fluid therapyCrystalloid fluid therapy
Crystalloid fluid therapy
santoshbhskr
 
NIV(NON INVASIVE VENTILATION)
NIV(NON INVASIVE  VENTILATION)NIV(NON INVASIVE  VENTILATION)
NIV(NON INVASIVE VENTILATION)
santoshbhskr
 
Icu echocardiography
Icu echocardiographyIcu echocardiography
Icu echocardiography
santoshbhskr
 

More from santoshbhskr (16)

Ats guidelines for cap 2019
Ats guidelines for cap 2019Ats guidelines for cap 2019
Ats guidelines for cap 2019
 
Fluid Therapy in critically ill
Fluid Therapy  in critically illFluid Therapy  in critically ill
Fluid Therapy in critically ill
 
Perioperative optimisation for surgery
Perioperative optimisation for surgeryPerioperative optimisation for surgery
Perioperative optimisation for surgery
 
Kill chararteristic of antibiotics
Kill chararteristic of antibioticsKill chararteristic of antibiotics
Kill chararteristic of antibiotics
 
Complicated intra abdominal infection
Complicated intra abdominal infectionComplicated intra abdominal infection
Complicated intra abdominal infection
 
Hyperglycemia in critically ill patients
Hyperglycemia in critically ill patientsHyperglycemia in critically ill patients
Hyperglycemia in critically ill patients
 
Acute Kidney injury in icu
Acute Kidney injury in icuAcute Kidney injury in icu
Acute Kidney injury in icu
 
Prevention of adverse drug events in hospital
Prevention of adverse drug events  in hospitalPrevention of adverse drug events  in hospital
Prevention of adverse drug events in hospital
 
Thromboprophylaxis in icu
Thromboprophylaxis in icuThromboprophylaxis in icu
Thromboprophylaxis in icu
 
Nutritional requirement in critically ill
Nutritional requirement in  critically illNutritional requirement in  critically ill
Nutritional requirement in critically ill
 
Anticoagulation guidelines recent update 2016
Anticoagulation guidelines recent update 2016Anticoagulation guidelines recent update 2016
Anticoagulation guidelines recent update 2016
 
Ventilation quiz question
Ventilation  quiz questionVentilation  quiz question
Ventilation quiz question
 
Case study myasthenia gravis
Case study myasthenia gravisCase study myasthenia gravis
Case study myasthenia gravis
 
Crystalloid fluid therapy
Crystalloid fluid therapyCrystalloid fluid therapy
Crystalloid fluid therapy
 
NIV(NON INVASIVE VENTILATION)
NIV(NON INVASIVE  VENTILATION)NIV(NON INVASIVE  VENTILATION)
NIV(NON INVASIVE VENTILATION)
 
Icu echocardiography
Icu echocardiographyIcu echocardiography
Icu echocardiography
 

Recently uploaded

Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 

Haemostatic resuscitation

  • 1. Dr Santosh Kumar Bhaskar Professor Anaesthesiology Chirayu Medical College Haemostatic Resuscitation
  • 2. A 65-year-old male with a past history of ischaemic heart disease is admitted to the ICU after a motorcycle crash having sustained long bone fractures of the lower limbs. He has no head, chest or abdominal injuries. Prior to surgery, his Glasgow Coma Scale (GCS) was 15 and Sp02 was 98% on 4 L/min oxygen via a Hudson mask, and chest X-ray was normal. He required prolonged operative fixation of his fractures and that was complicated by significant blood loss. Intra-operatively, he also developed an increasing oxygen requirement. On arrival in ICU, his most recent arterial blood gas, taken on a Fi02 of 0.7 shows Pa02 of 55 mmHg (7.3 kPa).
  • 3.
  • 4. Definition of hemostatic resuscitation  Rapid correction of haemostasis- impairing factors, such as hypothermia hypocalcemia and acidosis  Resuscitation with a balanced combination of blood products, which in combination resemble the composition of whole blood, aiming to avoid dilutional coagulopathy.
  • 5. resuscitation:  Reverse hypothermia  Reverse acidosis  Limit crystalloid load  Use blood components in a proportion which resembles whole blood  Reverse fibrinolysis associated with massive blood loss  Achieve this whole-blood-like ratio within the first 6 hours of resuscitation
  • 6. Rationale for aggressive correction of coagulopathy  Exsanguination is a major cause of death in trauma (40% of trauma-related death in the first 24 hours is due to haemorrhage)  Coagulopathy is common: 25% of severe trauma patients are coagulopathic at presentation  According to retrospective cohort studies (MacLeod et al, 2003) and the coagulopathic patients have increased mortality (46%) compared to non- coagulopathic controls (11%).
  • 7. Rationale for avoiding large volumes of crystalloid  Aggressive resuscitation with crystalloid leads to haemodilution.  Haemodilution decreases the concentration of clotting factors and leads to coagulopathy.  75% of the crystalloid volume load distributes into the extravascular space; organ and tissue oedema ensues, putting the patient at risk of pulmonary oedema and abdominal compartment syndrome (among other problems).  Crystalloids do not contribute to the transport of oxygen; by diluting the blood they actually decrease its oxygen-carrying capacity.  In the case of saline, crystalloid resuscitation may exacerbate the acidosis.
  • 8. Rationale for using a balanced blood product ratio  Transfusion of packed red cells does not restore clotting factors.  Coagulopathy will develop if packed red cells are the sole resuscitation fluid.  Transfused PRBCs suffer from storage lesions. Their oxygen-carrying capacity isn't very good anyway.  The citrate in the PRBCs tends to chelate the patient's calcium; this can't be good for their clotting function.  It stands to reason that whole blood is the best resuscitation fluid to replace whole blood which is lost by haemorrhage.  A "balanced" ratio of blood products resembles whole blood.  The precise ratio of platelets plasma and PRBCs is still being debated.
  • 9. Rationale for correction of acidosis  Nonsurvivors of trauma are more likely to have been acidotic than survivors  Acidosis in trauma is largely the consequence of raised lactate  The lactate is generated not only by tissue anaerobic metabolism, but also by the β-agonist adrenergic effects of endogenous catecholamines.  The main problems with acidosis in trauma is its influence on coagulopathy and haemodynamic performance (Lier et al, 2008). In fact, acidosis seems to be more important for coagulopathy than the hypothermia (Hoffman et al, 2004)
  • 10. Coagulopathy due to acidosis is the result of multiple pathophysiological processes  The main problem is impaired thrombin generation. The thrombin generation rate during the propagation phase is impaired by 50% at a pH of 7.10.  Platelet structure changes at a pH below 7.4: they assume a spherical shape, and lose their pseudopodia.  Clotting factors function poorly -particularly Factors V, VIIa and X- because the interaction between the clotting factors and negatively charged phospholipids is impaired at low pH (Hess et al, 2006).  Decreased availability of ionised calcium (due to the change in its protein binding dynamics)- therefore, poor clotting function.  Clotting factors which require iCa2+ have a decreased affinity for it at a low pH.
  • 11.  The haemodynamic effects of metabolic acidosis are also counterproductive, particularly if the pH is below 7.10:. Specific problems are listed as follows. Decreased cardiac output Increased propensity to arrhythmias Decreased systemic vascular tone and arterial vasodilation Decreased responsiveness to catecholamines Pulmonary vasoconstricition
  • 12. Rationale for correcting hypothermia  Hypothermia seems to have a real impact on trauma outcomes: in a retrospective analysis of trauma patients (Jurkovich et al, 1987), the temperature was associated with the following mortality rates:  Presenting temperature of over 34°C = mortality of 7%;  33-34°C = mortality of 40%;  32-33°C = mortality of 67%,  Under 32°C = mortality of 100%,
  • 13. Effects  In short, at 33°C the clotting activity is suppressed to the point where it resembles a 50% reduction in clotting factor concentration (even when the actual concentration is normal). Interestingly, recombinant Factor VIIa (Novoseven) still retains its activity at 34°C (+/- 2.5°C).  Platelet activity is also impaired at low temperature;Each 1°C decrease in temperature results in a 15% decrease in the rate of thromboxane B2 production (thus, platelet
  • 14. Rationale for correction of fibrinolysis with tranexamic acid  One of the effects of trauma is to induce a hyperfibrinolytic state  The major source of this seem to be increased serum levels of thrombomodulin and tPA (Brohi et al, 2008)  It would therefore make sense to give a tPA inhibitor such as tranexamic acid or eta-aminocaproic acid
  • 15. Rationale for the use of hypertonic saline  After the resuscitation of trauma, massive tissue injury and ischemia/reperfusion produces an exaggerated systemic inflammatory response syndrome (SIRS) .  Extravasation and sequestration of neutrophils into vital organs is one of the main mechanisms of organ damage in this context  Hypertonic saline is said to have immunomodulatory effects, specifically affecting neutrophil migration (Angle et al, 2000) and decreasing the permeability of the blood-brain barrier.  As a hyperosmolar solution, it should theoretically expand the volume of extracellular fluid by osmotically "borrowing" water from the intracellular compartment-
  • 16. Problems with haemostatic resuscitation  The ideal resuscitation fluid would of course be whole blood. Unfortunately, this is usually not available. One may try to recombine stored blood products to achieve an end result which resembles whole blood, but it is never quite the same due to lesions of processing and storage.
  • 17.  All blood products suffering storage lesions are cold (contributing to hypothermia) and acidic (because of cellular metabolism in storage, as well as due to citrate-based storage media)  The infusion of massive amounts of blood products exposes the patient to risks of massive transfusion which are not trivial, and it is debatable whether these risks outweigh the risks of massive crystalloid load
  • 18.  Tranexamic acid may have prothrombotic effects which increase the risk of DVT in already DVT-prone trauma patients. Furthermore, the methodology of the major trial in support of its use makes it difficult to generalise its finding to the ICU setting
  • 19.  Hypertonic saline can theoretically increase the risk of bleeding by causing some sort of platelet function impairment (fortunately studies have demonstrated that one would need to replace 10% of their blood volume with hypertonic saline before one experiences any of these effects).
  • 20. Take home message  Immediate resuscitation:  Primary survey should include the assessment of core temperature.  Haemostasis by direct pressure wherever this is possible  ABG to determine the pH, lactate, haemoglobin level and ionised calcium  Activate the massive transfusion protocol in liason with local blood bank and haematology service
  • 21. Take home message  Organise transfusion: 1:1:1 FFP, platelets, PRBCs.  Haemoglobin level is not a valid transfusion trigger, nor can transfusion wait for haemoglobin levels to become available.  Any transfused blood products should be warmed with a heater. Six units of RBCs at 4ºC will reduce the body temperature of an average 70 kg adult by 1ºC.  Crystalloid is to be avoided unless there is no other option and haemodynamic performance if life-threateningly poor
  • 22. Take home message  Tranexamic acid 1g over 10 minutes  Correct ionised calcium  Commence warming the patient externally  Practice permissive hypotension is permitted by the absence of neurotrauma  Within the first 6 hours:
  • 23. Take home message  Coags data, plus/minus TEG or ROTEM (its utility and cost effectiveness over traditional coags is still being questioned) will guide the ongoing use of blood products.  Tranexamic acid 1g over 8 hours to chase the first dose (as per CRASH-2 protocol)  Cryoprecipitate 3-4g should be given if the fibrinogen level is below 1.0  Recombinant Factor VIIa (Novoseven) should be thought about if the coags are trending towards normal, and the patient is still exsanguinating (the dose should be 90 μg/kg)